Xuefang Liu
Overview
Explore the profile of Xuefang Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
620
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Liu X, Qiu Y, Chen D, Xiong J, Xia B, Chen C, et al.
Open Med (Wars)
. 2023 Dec;
18(1):20230876.
PMID: 38152330
The association of thyroid hormone antibodies and glycolipid metabolism indicators with Type 2 diabetes mellitus (T2DM) was explored. As the disease worsens, the levels of thyroglobulin antibody (TGAb), thyroid peroxidase...
12.
Zhao J, Han M, Tian Y, Zhao P, Liu X, Dong H, et al.
Curr Pharm Biotechnol
. 2023 Nov;
25(11):1466-1477.
PMID: 37921125
Background: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. N-acetylcysteine (NAC) is well known for its antioxidant properties, along with potential protective effects on COPD....
13.
Qin Y, Zhai J, Yang J, Li H, Tian Y, Liu X, et al.
Biomed Pharmacother
. 2023 Oct;
168:115614.
PMID: 37862971
Glycogen synthase kinase 3β (GSK3β) has been associated with sensing many different stimuli to trigger the NLRP3 inflammasome, which plays a crucial role in promoting the inflammatory response in diseases,...
14.
Liu X, Yu N, Lu H, Zhang P, Liu C, Liu Y
Aust Crit Care
. 2023 Aug;
37(2):338-345.
PMID: 37586897
Objectives: This meta-analysis evaluated the effect of opioids on constipation in ICU patients. Review Method Used: Systematic review and meta-analysis. Data Sources: PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure...
15.
Liu X, Li S, Xiong J, Chen D, Jiang C, Zeng L, et al.
Diabetes Metab Syndr Obes
. 2023 Aug;
16:2225-2232.
PMID: 37525823
Background: Thyroxine binding globulin (TBG) deficiency is a rare thyroid disease, mostly caused by genetic mutations and acquired by X-linked recessive inheritance. The clinical features of children with TBG deficiency...
16.
Wei Y, Liu X, Jiang Y, Guan Q, Tian Y, Li J, et al.
Phytomedicine
. 2023 Jul;
118:154980.
PMID: 37499344
Background: Airway epithelial barrier dysfunction is highly related to the pathogenesis of chronic obstructive pulmonary disease (COPD). Effective-component combination (ECC) derived from Bufei Yishen formula (BYF) is an effective treatment...
17.
Liu X, Zhu Q, Liu W, Zhang J
PeerJ
. 2023 May;
11:e15330.
PMID: 37187511
Zinc (Zn) is an important element in plants, but over-accumulation of Zn is harmful. It is well-known that brassinolide (BR) plays a key role in the regulation of abiotic stress...
18.
Liu X, Zhu Q, Liu W, Zhang J
Plant Signal Behav
. 2023 Apr;
18(1):2186640.
PMID: 37083111
Zinc (Zn) is an important element in plants, but over-accumulation of Zn is harmful. The phytohormone brassinosteroids (BRs) play a key role in regulating plant growth, development, and response to...
19.
Ma J, Liu X, Wei Y, Lu R, Xu K, Tian Y, et al.
Evid Based Complement Alternat Med
. 2023 Jan;
2022:9423435.
PMID: 36619199
Background: The effective-component compatibility of Bufei Yishen formula III (ECC-BYF III) with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has been shown to protect against chronic obstructive pulmonary...
20.
Li J, Li K, Tian Y, Zhao P, Liu X, Li M, et al.
Phytomedicine
. 2023 Jan;
109:154604.
PMID: 36610143
Background: Jinshui Huanxian formula (JHF) ameliorates idiopathic pulmonary fibrosis patients. Active compounds, including icariin, isoliquiritigenin, nobiletin, peimine, and paeoniflorin, deriving from JHF were combined as effective-component compatibility ECC of JHF...